These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1782415)

  • 21. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
    Sarosiek J; Bilski J; Murty VL; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1989 May; 84(5):506-10. PubMed ID: 2470250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viscous fingering of HCl through gastric mucin.
    Bhaskar KR; Garik P; Turner BS; Bradley JD; Bansil R; Stanley HE; LaMont JT
    Nature; 1992 Dec; 360(6403):458-61. PubMed ID: 1448168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric mucosal defense and cytoprotection: bench to bedside.
    Laine L; Takeuchi K; Tarnawski A
    Gastroenterology; 2008 Jul; 135(1):41-60. PubMed ID: 18549814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
    Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucus and pepsin role in gastric damage prevention by H2-receptor antagonists and antiulcer drugs.
    Impicciatore M; Morini G; Chiavarini M; Plazzi PV; Agosti A; Soldani G
    Acta Physiol Hung; 1984; 64(3-4):253-7. PubMed ID: 6152367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current concepts of gastroduodenal mucosal protection.
    Garner A; Flemström G; Allen A
    Scand J Gastroenterol Suppl; 1984; 92():78-80. PubMed ID: 6429845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroprotective agents in mucosal defense against Helicobacter pylori.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
    Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice.
    Henriksnäs J; Phillipson M; Storm M; Engstrand L; Soleimani M; Holm L
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G396-403. PubMed ID: 16614375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of combination treatment with famotidine and methylmethionine sulfonium chloride on the mucus barrier of rat gastric mucosa.
    Ichikawa T; Ito Y; Saegusa Y; Iwai T; Goso Y; Ikezawa T; Ishihara K
    J Gastroenterol Hepatol; 2009 Mar; 24(3):488-92. PubMed ID: 19175830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of endogenous prostaglandins in gastric secretion and mucosal defense.
    Cohen MM
    Clin Invest Med; 1987 May; 10(3):226-31. PubMed ID: 3040310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens.
    Sarosiek J; Marshall BJ; Peura DA; Hoffman S; Feng T; McCallum RW
    Am J Gastroenterol; 1991 Jun; 86(6):729-34. PubMed ID: 2038995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal defences and gastroduodenal disease.
    Tasman-Jones C; Maher C; Thomsen L; Lee SP; Vanderwee M
    Digestion; 1987; 37 Suppl 2():1-7. PubMed ID: 3622945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retardation of acid diffusion by pig gastric mucosa: a potential role in mucosal protection.
    Williams SE; Turnberg LA
    Gastroenterology; 1980 Aug; 79(2):299-304. PubMed ID: 7399234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
    Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of mucus in the protection of the gastroduodenal mucosa.
    Allen A; Hutton DA; Leonard AJ; Pearson JP; Sellers LA
    Scand J Gastroenterol Suppl; 1986; 125():71-8. PubMed ID: 3103205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Helicobacter pylori in peptic ulcer and gastric cancer].
    Matsukura N; Onda M; Yamashita K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secreted and membrane-bound mucins and idiopathic peptic ulcer disease.
    Niv Y; Boltin D
    Digestion; 2012; 86(3):258-63. PubMed ID: 23075498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.